CBD Life Sciences Inc. (OTC:CBDL) Reports Record-Breaking Growth and Strategic Expansion in 2024

Yesterday CBD Life Sciences Inc. (OTC:CBDL) moved on to the radars of investors after it came up with a key corporate update. In the news release, the company noted that the update provided further illustration of the strong growth and strategic advances that were changing the industry.

The Trigger

The company announced that 2024 proved to be a landmark year, and as of February 2024, CBD Life Sciences recorded a staggering 1405.46% growth in revenues. It was the highest revenue growth ever recorded by the company and further cemented its position as a dominant player in the CBD and wellness industries.

The Growth Story

The explosive growth recorded by the company was primarily a function of its bullish move into new retail markets in a big way. CBD Life Sciences moved into two of the world’s biggest retail platforms, Amazon Marketplace and Walmart Marketplace, which proved to be a game changer. The two platforms provided CBD Life Sciences with access to marketplaces, which generate yearly consumer spending of more than $950 billion.

Moreover, the demand for the company’s offerings remained stronger than ever. Additionally, the company’s new product launches, like Mellow Mornings-branded CBD coffee creamers and fast-action pain relief cream, found strong traction with consumers. The partnerships with important dispensaries marked the company’s entry into the cannabis market, and the move is expected to deliver strong growth in 2025.